Multiple UK reports describe new evidence that HPV vaccination is driving cervical cancer deaths among young women in England to effectively zero. Coverage citing a study published in The Lancet says women vaccinated in early adolescence have an almost non-existent risk of dying from cervical cancer before age 30. Several outlets also report that, for years, no deaths from cervical cancer have occurred among young women in England, framing the change as a direct result of the HPV vaccine rollout.
The reporting generally agrees that the study looks at outcomes for cohorts given the vaccine at around ages 12 to 13 and finds no observed cervical cancer deaths in the younger age groups covered. At least one outlet also quantifies impact in terms of lives saved, with estimates in the region of about 200 in England attributed to vaccination.
While the news focus is on the current outcomes, some sources add caution: falling HPV uptake rates may lead to more future cases and deaths if fewer eligible teenagers receive the jab. The articles also note that high-risk HPV types cause most cervical cancers, with thousands of new diagnoses still occurring each year in England.
